Pulmonary Emphysema Regional Distribution and Extent from Chest Computed Tomography is Associated with Pulmonary Function Impairment in COPD Patients.

Dados básicos

Código:
Estudo Clínico Académico
Protocolo:
Estudo Clínico Académico
EUDRACT:
NCT:
Centro:
Dotação:
Ano de início:
2021
Ano de conclusão:
Estudos observacionais Nacional Não Financiado Outros

Objectivos do projeto

Estudos Observacionais (STROBE statement); Natureza do Promotor: Academia – Tipo não comercial – Iniciativa do Investigador; Tipo de Centro: Unicêntrico – Cuidados Secundários

Documentos

  • Não há documentos

Participantes

Unidades de investigação

Stakeholders - Promotores

FMUP

Outputs do ensaio clínico


12-Gene Expression Signature: A Potential Key for Predicting Prognosis and Benefit to ACT for Resectable NSCLC Patients

Siqueira, A; (...); Leal, LF

Meeting Abstract. 2023


Atezolizumab in previously treated non-smallcell lung cancer patients

Serino, M; (...); Hespanhol, V

Meeting Abstract. 10.1183/13993003.congress-2021.PA2304. 2021


Clinical outcomes of patients with acute exacerbations in interstitial lung diseases

Martins, M. Ramos; (...); Morais, A.

Meeting Abstract. 10.1183/13993003.congress-2022.4266. 2022


Coexistence of pleuroparenchymal fibroelastosis and hypersensitivity pneumonitis - analysis of prognostic impact

Dias, S. C.; (...); Morais, A.

Meeting Abstract. 10.1183/13993003.congress-2022.4094. 2022


COVID-19 in interstitial lung diseases: are fibrotic ILDs associated with worse outcomes?

Serino, M.; (...); Novais-Bastos, H.

Meeting Abstract. 10.1183/13993003.congress-2022.3230. 2022


Deciphering the genetic tapestry: Insights into sarcoidosis across diverse populations with the MESARGEN Consortium

Rivera, V, Natalia; (...); Padyukov, Leonid

Meeting Abstract. 10.1183/13993003.congress-2024.OA952. 2024


Deregulated immune cell recruitment orchestrated by c-MET impairs pulmonary inflammation and fibrosis

Barbosa-Matos, Catarina; (...); Costa, Sandra

Article. 10.1186/s12931-024-02884-1. 2024

  • Open Access.

Diagnostic yield and safety of transbronchial lung cryobiopsy and surgical lung biopsy in interstitial lung diseases: a systematic review and meta-analysis

Rodrigues, I; (...); Bastos, H.

Article. 10.1183/16000617.0280-2021. 2022

  • Open Access.

Diagnostic yield and safety of transbronchial lung cryobiopsy and surgical lung biopsy in interstitial lung diseases: a systematic review and meta-analysis.

Rodrigues, I; (...); Bastos, HN

Review. 2022


Disease behaviour and prognostic factors in Hypersensitivity Pneumonitis with UIP-like pattern

Freitas Ferreira Araujo, Maria Joao; (...); Morais, Antonio

Meeting Abstract. 10.1183/13993003.congress-2021.OA2970. 2021


Distinct TNF-alpha and HLA polymorphisms associate with fibrotic and non-fibrotic subtypes of hypersensitivity pneumonitis

Freitas, C; (...); Morais, A

Article. 10.1016/j.pulmoe.2021.08.013. 2023

  • Open Access.

Efficacy and Safety of Indwelling Catheter for Malignant Pleural Effusions Related to Timing of Cancer Therapy: A Systematic Review

Porcel, JM; (...); Botana-Rial, M

Review. 10.1016/j.arbres.2023.06.007. 2023

  • Open Access.

Efficacy of mycophenolate mofetil in fibrotic hypersensitivity pneumonitis treatment

Torres Silva, Ana Filipa; (...); Morais, Antonio

Meeting Abstract. 10.1183/13993003.congress-2023.PA410. 2023


Endobronchial Obstruction by an Inflammatory Myofibroblastic Tumor

Silva, Bruno S., Sacramento, Maria Luisa, Novais e Bastos, Helder

Letter. 10.20344/amp.21664. 2024

  • Open Access.

Evolution of fibrotic interstitial lung diseases (ILD) after COVID-19

Ramos Martins, M.; (...); Morais, A.

Meeting Abstract. 10.1183/13993003.congress-2022.4172. 2022


Familial Pulmonary Fibrosis: experience from a tertiary hospital

Pinto, Josue; (...); Bastos, Helder Novais E.

Meeting Abstract. 10.1183/13993003.congress-2021.PA2370. 2021


Fungal stimulation induces a specific Th1-like immune response in hypersensitivity pneumonitis patients

Santos, Rita F.; (...); Bastos, Helder Novais

Meeting Abstract. 10.1183/13993003.congress-2024.PA2454. 2024


Home environmental fungal exposure in patients with Hypersensitivity Pneumonitis

Coelho, David Jorge Araujo Barros; (...); Morais, Antonio

Meeting Abstract. 10.1183/13993003.congress-2024.PA1581. 2024


Home environmental fungal exposure in patients with Hypersensitivity Pneumonitis - pilot analysis

Araujo Barros Coelho, D. J.; (...); Morais, A.

Meeting Abstract. 10.1183/13993003.congress-2022.4281. 2022


Hypersensitivity Pneumonitis with and without Autoimmune Features: a comparative analysis at diagnosis

Lourenco, Joana Catarina Neto; (...); Morais, Antonio

Meeting Abstract. 10.1183/13993003.congress-2024.PA1573. 2024


Immunotherapy in metastatic non-small cell lung cancer: EPSILoN as a prognostic score

Valente, MCA; (...); Hespanhol, V

Meeting Abstract. 10.1183/13993003.congress-2022.3572. 2022


Interventional bronchoscopy in lung cancer treatment

Rozman, Ales; (...); Hardavella, Georgia

Article. 10.1183/20734735.0201-2023. 2024

  • Open Access.

LUNG CARCINOID TUMORS: 10 YEARS OF EXPERIENCE

GUERRA, S. I.; (...); ARAUJO, D.

Meeting Abstract. 10.1016/j.chest.2021.12.338. 2022


Lymphangioleiomyomatosis - experience of a university hospital

Baptista, Mafalda Martins; (...); Morais, Antonio

Meeting Abstract. 10.1183/13993003.congress-2021.PA2371. 2021


Metabolic regulation of granulomatous inflammation by tryptophan catabolism

Oliveira, Marcela; (...); Carvalho, Agostinho

Meeting Abstract. 10.1183/13993003.congress-2024.PA2478. 2024


Modified Glasgow Prognostic Score - a predictor of survival in malignant pleural effusion

Martins, B; (...); Novais-Bastos, H

Meeting Abstract. 10.1183/13993003.congress-2021.PA3102. 2021


Monocyte/macrophage axis as potential drivers of Progressive Fibrosing Hypersensitivity Pneumonitis

Pinto, Ana; (...); Bastos, Helder Novais

Meeting Abstract. 10.1183/13993003.congress-2023.PA1164. 2023


Mortality risk prediction with ILD-GAP index in a fibrotic hypersensitivity pneumonitis cohort

Almeida, LM; (...); Morais, A

Article. 10.1177/17534666221135316. 2022

  • Open Access.

Mortality risk prediction with ILD-GAP index in a portuguese chronic hypersensitivity pneumonitis cohort

Gouveia Cardoso, Ana Catarina; (...); Morais, Antonio

Meeting Abstract. 10.1183/13993003.congress-2021.PA2249. 2021


OBSTRUCTIVE SLEEP APNEA IN NON-IPF FIBROTIC ILD PATIENTS: WHO, HOW AND WHAT SHOULD WE OFFER?

Gouveia Cardoso, C.; (...); Drummond, M.

Meeting Abstract. 2024


Pentraxin 3 Inhibits Complement-driven Macrophage Activation to Restrain Granuloma Formation in Sarcoidosis

Gonçales, RA; (...); Carvalho, A

Article. 10.1164/rccm.202112-2771OC. 2022

  • Open Access.

Pleuroparenchymal fibroelastosis as a complication of chemotherapy: A case report

Vieira, ACR; (...); Morais, A

Article. 10.3892/mco.2022.2504. 2022

  • Open Access.

Polymorphisms and haplotypes of TOLLIP and MUC5B are associated with susceptibility and survival in patients with fibrotic hypersensitivity pneumonitis

Mota P.C.; (...); Morais A.

Article. 10.1016/j.pulmoe.2024.01.002. 2024

  • Open Access.

Polymorphisms and haplotypes of TOLLIP and MUC5B are associated with susceptibility and survival in patients with fibrotic hypersensitivity pneumonitis.

Mota, PC; (...); Morais, A

Article. 2024


PREDICTIVE BIOMARKERS OF SEVERE IMMUNE-RELATED ADVERSE EVENTS IN NON-SMALL CELL LUNG CANCER

Magalhaes Ferreira, P.; (...); Hespanhol, V.

Meeting Abstract. 10.1016/j.chest.2021.12.341. 2022


Predictive value of common genetic variants in idiopathic pulmonary fibrosis survival

Mota, PC; (...); Morais, A

Article. 10.1007/s00109-022-02242-y. 2022


Predictive value of common genetic variants in idiopathic pulmonary fibrosis survival.

Mota, PC; (...); Morais, A

Article. 2022


Predictors of immune-related adverse events and outcomes in patients with NSCLC treated with immune-checkpoint inhibitors

Serino M.; (...); Hespanhol V.

Article. 10.1016/j.pulmoe.2022.03.003. 2024

  • Open Access.

Predictors of immune-related adverse events and outcomes in patients with NSCLC treated with immune-checkpoint inhibitors.

Serino, M; (...); Hespanhol, V

Article. 2024


Predictors of lung entrapment in malignant pleural effusion

Trovisco, R; (...); Bastos, HN

Article. 10.1016/j.pulmoe.2022.08.001. 2024

  • Open Access.

Predictors of lung entrapment in malignant pleural effusion.

Trovisco, R; (...); Bastos, HN

Article. 2024


PREDICTORS OF LUNG ENTRAPMENT IN PATIENTS WITH MALIGNANT PLEURAL EFFUSION

Serino, M.; (...); Novais-Bastos, H.

Meeting Abstract. 10.1016/j.chest.2021.12.311. 2022

  • Open Access.

PREDICTORS OF OVERALL SURVIVAL IN PATIENTS WITH MALIGNANT PLEURAL EFFUSION

Serino, M.; (...); Novais-Bastos, H.

Meeting Abstract. 10.1016/j.chest.2021.12.310. 2022

  • Open Access.

Predictors of pneumothorax after transbronchial lung cryobiopsy for diagnosis of interstitial lung diseases

Cardoso, Ana Catarina Gouveia; (...); Novais-Bastos, Helder

Meeting Abstract. 10.1183/13993003.congress-2021.PA852. 2021


Predictors of survival and technical success of bronchoscopic interventions in malignant airway obstruction

Freitas, Claudia; (...); Fernandes, Gabriela

Article. 10.21037/jtd-21-1393. 2021

  • Open Access.

Pulmonary Emphysema Regional Distribution and Extent Assessed by Chest Computed Tomography Is Associated With Pulmonary Function Impairment in Patients With COPD

Gomes, P; (...); Carvalho, ARS

Article. 10.3389/fmed.2021.705184. 2021

  • Open Access.

Reproducibility of a 12-gene set for predicting outcome and benefit from ACT in earlystage NSCLC patients

Siqueira, Alexia Polo; (...); Reis, Rui

Meeting Abstract. 10.1183/13993003.congress-2023.OA1451. 2023


Risk Factors for Acute Exacerbations of Fibrotic Hypersensitivity Pneumonitis-Is Exposure a Trigger That We're Missing?

Coelho, DB; (...); Melo, N

Letter. 10.1016/j.arbres.2022.07.004. 2023


RISK FACTORS FOR ACUTE EXACERBATIONS OF HYPERSENSITIVITY PNEUMONITIS

BARROS COELHO, D.; (...); MELO, N.

Meeting Abstract. 10.1016/j.chest.2021.12.280. 2022

  • Open Access.

Serum metalloproteinase 7 as a biomarker of progressive pulmonary fibrosis

Araújo, M; (...); Morais, A

Meeting Abstract. 10.1183/13993003.congress-2023.PA1155. 2023


Serum metalloproteinase-7 as a biomarker of progressive pulmonary fibrosis

Beltr?o, M; (...); Ara?jo, M

Article. 10.1183/23120541.00553-2024. 2024

  • Open Access.

SOMATOSTATIN ANALOGS IN THE TREATMENT OF LUNG CARCINOID TUMORS: AN EXPERIENCE OF A LARGE CENTER

Valente, A.; (...); Queiroga, H.

Meeting Abstract. 10.1016/j.chest.2021.12.347. 2022

  • Open Access.

Spread through air spaces prognostic value in adenocarcinoma

Silva Sousa, Mara Daniela; (...); Freitas, Claudia

Meeting Abstract. 10.1183/13993003.congress-2023.PA2214. 2023


The impact of nintedanib and pirfenidone on lung function and survival in patients with idiopathic pulmonary fibrosis in real-life setting

Santos, G; (...); Morais, A

Article. 10.1016/j.pupt.2023.102261. 2023


The impact of nintedanib and pirfenidone on lung function and survival in patients with idiopathic pulmonary fibrosis in real-life setting.

Santos, G; (...); Morais, A

Article. 2023


The Role of Ultrasonography in the Diagnosis and Decision Algorithm for the Management of Pneumothorax after Transbronchial Lung Cryobiopsy

Coelho, DB; (...); Bastos, H.

Article. 10.1159/000518140. 2021


Transbronchial lung cryobiopsy for the diagnosis of Fibrotic Hypersensitivity Pneumonitis

Ferreira, Pedro Magalhaes; (...); Morais, Antonio

Meeting Abstract. 10.1183/13993003.congress-2023.PA2919. 2023


Unveiling common molecular pathways linked to ILDs with progressive fibrosing phenotype: the role of MUC5B promoter variants

Santos, Rita; (...); Bastos, Helder Novais

Meeting Abstract. 10.1183/13993003.congress-2023.OA854. 2023


Validation of a 5-gene signature for predicting outcomes in early-stage NSCLC patients

Miranda, Keila Cristina; (...); Reis, Rui

Meeting Abstract. 10.1183/13993003.congress-2023.OA1449. 2023


Partilhar